Terms: = Liver cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
25 results:
1. Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.
Lin K; Xia B; Wang X; He X; Zhou M; Lin Y; Qiao Y; Li R; Chen Q; Li Y; Feng J; Chen T; Chen C; Li X; Zhang H; Lu L; Liu B; Zhang X
J Transl Med; 2024 Apr; 22(1):349. PubMed ID: 38610029
[TBL] [Abstract] [Full Text] [Related]
2. Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report.
Kompani F; Safari Sharari A; Haji Esmaeil Memar E; Ghahremanloo M
Arch Iran Med; 2024 Jan; 27(1):44-47. PubMed ID: 38431960
[TBL] [Abstract] [Full Text] [Related]
3. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley MB; Berg FM; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
J Control Release; 2024 Mar; 367():135-147. PubMed ID: 38237687
[TBL] [Abstract] [Full Text] [Related]
4. Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.
Tian H; Shang H; Chen Y; Wu B; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():7079-7092. PubMed ID: 38050474
[TBL] [Abstract] [Full Text] [Related]
5. IR-820@nbs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy.
Wang X; Wang C; Tian H; Chen Y; Wu B; Cheng W
Int J Nanomedicine; 2023; 18():6199-6212. PubMed ID: 37933299
[TBL] [Abstract] [Full Text] [Related]
6. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
[TBL] [Abstract] [Full Text] [Related]
7.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
8. Plasma Circulating Cell-free DNA in Advanced Hepatocellular Carcinoma Patients Treated With Radiation Therapy.
Kim DY; Cho EH; Kim JS; Chie EK; Kang HC
In Vivo; 2023; 37(5):2306-2313. PubMed ID: 37652507
[TBL] [Abstract] [Full Text] [Related]
9. Laparoscopic Anatomical liver Resection of Segment VIII by Using ICG Fluorescence Positive Staining Under the Guidance of Laparoscopic Ultrasonography.
Sun J; Lu ZY; Zhai JX; Lang MR; Wang HG
Ann Surg Oncol; 2023 Nov; 30(12):7358-7359. PubMed ID: 37556011
[TBL] [Abstract] [Full Text] [Related]
10. Chrysin reduces hypercholesterolemia-mediated atherosclerosis through modulating oxidative stress, microflora, and apoptosis in experimental rats.
Yuvaraj S; Sasikumar S; Puhari SSM; Ramprasath T; Baskaran N; Vasudevan V; Selvam GS
J Food Biochem; 2022 Nov; 46(11):e14349. PubMed ID: 35892244
[TBL] [Abstract] [Full Text] [Related]
11. RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the treatment of HCC.
Chen Y; Shang H; Wang C; Zeng J; Zhang S; Wu B; Cheng W
Int J Nanomedicine; 2022; 17():105-123. PubMed ID: 35027829
[TBL] [Abstract] [Full Text] [Related]
12. Laparoscopic Segmentectomy IV Using Hepatic Round Ligament Approach Combined with Fluorescent Negative Staining Method.
Zheng K; He D; Liao A; Wu H; Yang J; Jiang L
Ann Surg Oncol; 2022 May; 29(5):2980-2981. PubMed ID: 34994890
[TBL] [Abstract] [Full Text] [Related]
13. Oxygen-sufficient lipid nanobubbles combined with UTMD for enhanced sonodynamic therapy of Hep-G2 cells.
Tan H; Tian Y; Yang H; Liu Z; Liang X; Li B; Cheng W
J Biomed Mater Res B Appl Biomater; 2021 Nov; 109(11):1796-1806. PubMed ID: 33838006
[TBL] [Abstract] [Full Text] [Related]
14. Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma.
Yang H; Jing H; Han X; Tan H; Cheng W
Drug Des Devel Ther; 2021; 15():531-542. PubMed ID: 33603343
[TBL] [Abstract] [Full Text] [Related]
15. Enhanced shRNA delivery by the combination of polyethylenimine, ultrasound, and nanobubbles in liver cancer.
Li H; Wang Z; Zhang J; Yuan C; Zhang H; Hou X; Zhang D
Technol Health Care; 2019; 27(S1):263-272. PubMed ID: 31045545
[TBL] [Abstract] [Full Text] [Related]
16. Anorectal Malignant Melanoma: Retrospective Analysis of Six Patients and Review of the Literature.
Atak I
Prague Med Rep; 2018; 119(2-3):97-106. PubMed ID: 30414360
[TBL] [Abstract] [Full Text] [Related]
17. An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
Zhang B; Chen M; Zhang Y; Chen W; Zhang L; Chen L
PLoS One; 2018; 13(5):e0196686. PubMed ID: 29718963
[TBL] [Abstract] [Full Text] [Related]
18. Design and screening of a chimeric survivin-specific nanobody and its anticancer activities in vitro.
Zhang N; Guo H; Zheng W; Wang T; Ma X
Anticancer Drugs; 2016 Oct; 27(9):839-47. PubMed ID: 27362789
[TBL] [Abstract] [Full Text] [Related]
19. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract] [Full Text] [Related]
20. A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization.
Ma J; Zhang D; Ying X; Zhao Y; He C; Zhu Q; Han S
Curr Cancer Drug Targets; 2015; 15(6):533-41. PubMed ID: 25850444
[TBL] [Abstract] [Full Text] [Related]
[Next]